Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Immunomodulation Induced by Host Pathogen Interaction.

Yassine HM, Moin SM, Cyprian FS, Wheatley AK, Nasrallah GK.

J Immunol Res. 2019 Aug 29;2019:9710910. doi: 10.1155/2019/9710910. eCollection 2019. No abstract available.

2.

Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms.

Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM.

Viruses. 2019 Aug 19;11(8). pii: E762. doi: 10.3390/v11080762. Review.

3.

Impact of Physical Exercise on Gut Microbiome, Inflammation, and the Pathobiology of Metabolic Disorders.

Sohail MU, Yassine HM, Sohail A, Al Thani AA.

Rev Diabet Stud. 2019;15:35-48. doi: 10.1900/RDS.2019.15.35. Epub 2019 Aug 4.

PMID:
31380886
4.

Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin.

Andrews SF, Chambers MJ, Schramm CA, Plyler J, Raab JE, Kanekiyo M, Gillespie RA, Ransier A, Darko S, Hu J, Chen X, Yassine HM, Boyington JC, Crank MC, Chen GL, Coates E, Mascola JR, Douek DC, Graham BS, Ledgerwood JE, McDermott AB.

Immunity. 2019 Aug 20;51(2):398-410.e5. doi: 10.1016/j.immuni.2019.06.024. Epub 2019 Jul 23.

PMID:
31350180
5.

Epidemiology of respiratory infections among adults in Qatar (2012-2017).

Al-Romaihi HE, Smatti MK, Ganesan N, Nadeem S, Farag E, Coyle PV, Nader JD, Al-Khatib HA, Elmagboul EB, Al Dhahry S, Al-Marri SA, Al Thani AA, Al Khal A, Al Maslamani MA, Yassine HM.

PLoS One. 2019 Jun 13;14(6):e0218097. doi: 10.1371/journal.pone.0218097. eCollection 2019.

6.

Demographics and Epidemiology of Hepatitis B in the State of Qatar: A Five-Year Surveillance-Based Incidence Study.

Al Romaihi HE, Ganesan N, Farag EA, Smatti MK, Nasrallah GK, Himatt SM, Derbala MF, Alshamali M, Mahadoon LK, Khogali HS, Sallam M, Al Thani AA, Al Thani M, Al Kaabi S, Yassine HM.

Pathogens. 2019 May 21;8(2). pii: E68. doi: 10.3390/pathogens8020068.

7.

Hepatitis B Virus Molecular Epidemiology, Host-Virus Interaction, Coinfection, and Laboratory Diagnosis in the MENA Region: An Update.

Al-Sadeq DW, Taleb SA, Zaied RE, Fahad SM, Smatti MK, Rizeq BR, Al Thani AA, Yassine HM, Nasrallah GK.

Pathogens. 2019 May 11;8(2). pii: E63. doi: 10.3390/pathogens8020063. Review.

8.

Epidemiological, Molecular, and Clinical Features of Norovirus Infections among Pediatric Patients in Qatar.

Mathew S, Alansari K, K Smatti M, Zaraket H, Al Thani AA, Yassine HM.

Viruses. 2019 Apr 29;11(5). pii: E400. doi: 10.3390/v11050400.

9.

Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses.

Kanekiyo M, Joyce MG, Gillespie RA, Gallagher JR, Andrews SF, Yassine HM, Wheatley AK, Fisher BE, Ambrozak DR, Creanga A, Leung K, Yang ES, Boyoglu-Barnum S, Georgiev IS, Tsybovsky Y, Prabhakaran MS, Andersen H, Kong WP, Baxa U, Zephir KL, Ledgerwood JE, Koup RA, Kwong PD, Harris AK, McDermott AB, Mascola JR, Graham BS.

Nat Immunol. 2019 Jun;20(6):765. doi: 10.1038/s41590-019-0395-0.

PMID:
30980067
10.

Epidemiological and genetic characterization of pH1N1 and H3N2 influenza viruses circulated in MENA region during 2009-2017.

Al Khatib HA, Al Thani AA, Gallouzi I, Yassine HM.

BMC Infect Dis. 2019 Apr 11;19(1):314. doi: 10.1186/s12879-019-3930-6.

11.

Expression profile of MicroRNA: An Emerging Hallmark of Cancer.

Zaheer U, Faheem M, Qadri I, Begum N, Yassine HM, Al Thani AA, Mathew S.

Curr Pharm Des. 2019;25(6):642-653. doi: 10.2174/1386207322666190325122821.

PMID:
30914015
12.

Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in Qatar.

Al Kahlout RA, Nasrallah GK, Farag EA, Wang L, Lattwein E, Müller MA, El Zowalaty ME, Al Romaihi HE, Graham BS, Al Thani AA, Yassine HM.

J Immunol Res. 2019 Feb 18;2019:1386740. doi: 10.1155/2019/1386740. eCollection 2019.

13.

Herbal medicine as an auspicious therapeutic approach for the eradication of Helicobacter pylori infection: A concise review.

Ghasemian A, Fattahi A, Shokouhi Mostafavi SK, Almarzoqi AH, Memariani M, Ben Braiek O, Yassine HM, Mostafavi NSS, Ahmed MM, Mirforughi SA.

J Cell Physiol. 2019 Aug;234(10):16847-16860. doi: 10.1002/jcp.28363. Epub 2019 Mar 7. Review.

PMID:
30847906
14.

Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages.

Corbett KS, Moin SM, Yassine HM, Cagigi A, Kanekiyo M, Boyoglu-Barnum S, Myers SI, Tsybovsky Y, Wheatley AK, Schramm CA, Gillespie RA, Shi W, Wang L, Zhang Y, Andrews SF, Joyce MG, Crank MC, Douek DC, McDermott AB, Mascola JR, Graham BS, Boyington JC.

MBio. 2019 Feb 26;10(1). pii: e02810-18. doi: 10.1128/mBio.02810-18.

15.

Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses.

Kanekiyo M, Joyce MG, Gillespie RA, Gallagher JR, Andrews SF, Yassine HM, Wheatley AK, Fisher BE, Ambrozak DR, Creanga A, Leung K, Yang ES, Boyoglu-Barnum S, Georgiev IS, Tsybovsky Y, Prabhakaran MS, Andersen H, Kong WP, Baxa U, Zephir KL, Ledgerwood JE, Koup RA, Kwong PD, Harris AK, McDermott AB, Mascola JR, Graham BS.

Nat Immunol. 2019 Mar;20(3):362-372. doi: 10.1038/s41590-018-0305-x. Epub 2019 Feb 11. Erratum in: Nat Immunol. 2019 Apr 12;:.

16.

Mixed Viral-Bacterial Infections and Their Effects on Gut Microbiota and Clinical Illnesses in Children.

Mathew S, Smatti MK, Al Ansari K, Nasrallah GK, Al Thani AA, Yassine HM.

Sci Rep. 2019 Jan 29;9(1):865. doi: 10.1038/s41598-018-37162-w.

17.

Impaired Liver Size and Compromised Neurobehavioral Activity are Elicited by Chitosan Nanoparticles in the Zebrafish Embryo Model.

Abou-Saleh H, Younes N, Rasool K, Younis MH, Prieto RM, Yassine HM, Mahmoud KA, Pintus G, Nasrallah GK.

Nanomaterials (Basel). 2019 Jan 19;9(1). pii: E122. doi: 10.3390/nano9010122.

18.

Viral-Induced Enhanced Disease Illness.

Smatti MK, Al Thani AA, Yassine HM.

Front Microbiol. 2018 Dec 5;9:2991. doi: 10.3389/fmicb.2018.02991. eCollection 2018. Review.

19.

Corrigendum: Performance evaluation of five commercial assays in assessing seroprevalence of HEV antibodies among blood donors.

Al-Absi ES, Al-Sadeq DW, Younis MH, Yassine HM, Abdalla OM, Mesleh AG, Hadwan TA, Amimo JO, Thalib L, Nasrallah GK.

J Med Microbiol. 2019 Jan;68(1):115. doi: 10.1099/jmm.0.000880. Epub 2018 Nov 15. No abstract available.

PMID:
30431419
20.

The Dual Specificity Role of Transcription Factor FOXO in Type 2-diabetes and Cancer.

Fatima K, Mathew S, Faheem M, Mehmood T, Yassine HM, Al Thani AA, Abdel-Hafiz H, Al Ghamdy K, Qadri I.

Curr Pharm Des. 2018;24(24):2839-2848. doi: 10.2174/1381612824666180911114210.

PMID:
30205794
21.

Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors.

Mathew S, Al Thani AA, Yassine HM.

PLoS One. 2018 Sep 4;13(9):e0203148. doi: 10.1371/journal.pone.0203148. eCollection 2018.

22.

Molecular characterization of extended spectrum β -lactamases enterobacteriaceae causing lower urinary tract infection among pediatric population.

Eltai NO, Al Thani AA, Al-Ansari K, Deshmukh AS, Wehedy E, Al-Hadidi SH, Yassine HM.

Antimicrob Resist Infect Control. 2018 Jul 28;7:90. doi: 10.1186/s13756-018-0381-6. eCollection 2018.

23.

Evolution and dynamics of the pandemic H1N1 influenza hemagglutinin protein from 2009 to 2017.

Al Khatib HA, Al Thani AA, Yassine HM.

Arch Virol. 2018 Nov;163(11):3035-3049. doi: 10.1007/s00705-018-3962-z. Epub 2018 Jul 31.

PMID:
30066273
24.

Performance evaluation of five commercial assays in assessing seroprevalence of HEV antibodies among blood donors.

Al-Absi ES, Al-Sadeq DW, Younis MH, Yassine HM, Abdalla OM, Mesleh AG, Hadwan TA, Amimo JO, Thalib L, Nasrallah GK.

J Med Microbiol. 2018 Sep;67(9):1302-1309. doi: 10.1099/jmm.0.000807. Epub 2018 Jul 27. Erratum in: J Med Microbiol. 2019 Jan;68(1):115.

PMID:
30051802
25.

Prevalence of antibiotic resistant Escherichia coli isolates from fecal samples of food handlers in Qatar.

Eltai NO, Yassine HM, Al Thani AA, Abu Madi MA, Ismail A, Ibrahim E, Alali WQ.

Antimicrob Resist Infect Control. 2018 Jun 26;7:78. doi: 10.1186/s13756-018-0369-2. eCollection 2018.

26.

Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches.

Taleb SA, Al Thani AA, Al Ansari K, Yassine HM.

Eur J Clin Microbiol Infect Dis. 2018 Oct;37(10):1817-1827. doi: 10.1007/s10096-018-3289-4. Epub 2018 Jun 6. Review.

PMID:
29876771
27.

Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera.

Yassine HM, McTamney PM, Boyington JC, Ruckwardt TJ, Crank MC, Smatti MK, Ledgerwood JE, Graham BS.

Sci Rep. 2018 Jun 5;8(1):8628. doi: 10.1038/s41598-018-26538-7.

28.

Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens.

Georgiev IS, Joyce MG, Chen RE, Leung K, McKee K, Druz A, Van Galen JG, Kanekiyo M, Tsybovsky Y, Yang ES, Yang Y, Acharya P, Pancera M, Thomas PV, Wanninger T, Yassine HM, Baxa U, Doria-Rose NA, Cheng C, Graham BS, Mascola JR, Kwong PD.

ACS Infect Dis. 2018 May 11;4(5):788-796. doi: 10.1021/acsinfecdis.7b00192. Epub 2018 Mar 6.

PMID:
29451984
29.

Antibiotic Resistance Profile of Commensal Escherichia coli Isolated from Broiler Chickens in Qatar.

Eltai NO, Abdfarag EA, Al-Romaihi H, Wehedy E, Mahmoud MH, Alawad OK, Al-Hajri MM, Al Thani AA, Yassine HM.

J Food Prot. 2018 Feb;81(2):302-307. doi: 10.4315/0362-028X.JFP-17-191.

PMID:
29369690
30.

Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar.

Smatti MK, Yassine HM, AbuOdeh R, AlMarawani A, Taleb SA, Althani AA, Nasrallah GK.

PLoS One. 2017 Dec 11;12(12):e0189033. doi: 10.1371/journal.pone.0189033. eCollection 2017.

31.

Improving Influenza Vaccination Rate among Primary Healthcare Workers in Qatar.

Elawad KH, Farag EA, Abuelgasim DA, Smatti MK, Al-Romaihi HE, Al Thani M, Al Mujalli H, Shehata Z, Alex M, Al Thani AA, Yassine HM.

Vaccines (Basel). 2017 Oct 10;5(4). pii: E36. doi: 10.3390/vaccines5040036.

32.

Reconstituted B cell receptor signaling reveals carbohydrate-dependent mode of activation.

Villar RF, Patel J, Weaver GC, Kanekiyo M, Wheatley AK, Yassine HM, Costello CE, Chandler KB, McTamney PM, Nabel GJ, McDermott AB, Mascola JR, Carr SA, Lingwood D.

Sci Rep. 2016 Oct 31;6:36298. doi: 10.1038/srep36298.

33.

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses.

Joyce MG, Wheatley AK, Thomas PV, Chuang GY, Soto C, Bailer RT, Druz A, Georgiev IS, Gillespie RA, Kanekiyo M, Kong WP, Leung K, Narpala SN, Prabhakaran MS, Yang ES, Zhang B, Zhang Y, Asokan M, Boyington JC, Bylund T, Darko S, Lees CR, Ransier A, Shen CH, Wang L, Whittle JR, Wu X, Yassine HM, Santos C, Matsuoka Y, Tsybovsky Y, Baxa U; NISC Comparative Sequencing Program, Mullikin JC, Subbarao K, Douek DC, Graham BS, Koup RA, Ledgerwood JE, Roederer M, Shapiro L, Kwong PD, Mascola JR, McDermott AB.

Cell. 2016 Jul 28;166(3):609-623. doi: 10.1016/j.cell.2016.06.043. Epub 2016 Jul 21.

34.

Pre-fusion structure of a human coronavirus spike protein.

Kirchdoerfer RN, Cottrell CA, Wang N, Pallesen J, Yassine HM, Turner HL, Corbett KS, Graham BS, McLellan JS, Ward AB.

Nature. 2016 Mar 3;531(7592):118-21. doi: 10.1038/nature17200.

35.

Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera.

Ngwuta JO, Chen M, Modjarrad K, Joyce MG, Kanekiyo M, Kumar A, Yassine HM, Moin SM, Killikelly AM, Chuang GY, Druz A, Georgiev IS, Rundlet EJ, Sastry M, Stewart-Jones GB, Yang Y, Zhang B, Nason MC, Capella C, Peeples ME, Ledgerwood JE, McLellan JS, Kwong PD, Graham BS.

Sci Transl Med. 2015 Oct 14;7(309):309ra162. doi: 10.1126/scitranslmed.aac4241.

36.

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection.

Yassine HM, Boyington JC, McTamney PM, Wei CJ, Kanekiyo M, Kong WP, Gallagher JR, Wang L, Zhang Y, Joyce MG, Lingwood D, Moin SM, Andersen H, Okuno Y, Rao SS, Harris AK, Kwong PD, Mascola JR, Nabel GJ, Graham BS.

Nat Med. 2015 Sep;21(9):1065-70. doi: 10.1038/nm.3927. Epub 2015 Aug 24.

PMID:
26301691
37.

Evaluation of candidate vaccine approaches for MERS-CoV.

Wang L, Shi W, Joyce MG, Modjarrad K, Zhang Y, Leung K, Lees CR, Zhou T, Yassine HM, Kanekiyo M, Yang ZY, Chen X, Becker MM, Freeman M, Vogel L, Johnson JC, Olinger G, Todd JP, Bagci U, Solomon J, Mollura DJ, Hensley L, Jahrling P, Denison MR, Rao SS, Subbarao K, Kwong PD, Mascola JR, Kong WP, Graham BS.

Nat Commun. 2015 Jul 28;6:7712. doi: 10.1038/ncomms8712.

38.

H5N1 Vaccine-Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem.

Wheatley AK, Whittle JR, Lingwood D, Kanekiyo M, Yassine HM, Ma SS, Narpala SR, Prabhakaran MS, Matus-Nicodemos RA, Bailer RT, Nabel GJ, Graham BS, Ledgerwood JE, Koup RA, McDermott AB.

J Immunol. 2015 Jul 15;195(2):602-10. doi: 10.4049/jimmunol.1402835. Epub 2015 Jun 15.

39.

Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages.

Whittle JR, Wheatley AK, Wu L, Lingwood D, Kanekiyo M, Ma SS, Narpala SR, Yassine HM, Frank GM, Yewdell JW, Ledgerwood JE, Wei CJ, McDermott AB, Graham BS, Koup RA, Nabel GJ.

J Virol. 2014 Apr;88(8):4047-57. doi: 10.1128/JVI.03422-13. Epub 2014 Feb 5.

40.

Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies.

Kanekiyo M, Wei CJ, Yassine HM, McTamney PM, Boyington JC, Whittle JR, Rao SS, Kong WP, Wang L, Nabel GJ.

Nature. 2013 Jul 4;499(7456):102-6. doi: 10.1038/nature12202. Epub 2013 May 22.

PMID:
23698367
41.

Structural and genetic basis for development of broadly neutralizing influenza antibodies.

Lingwood D, McTamney PM, Yassine HM, Whittle JR, Guo X, Boyington JC, Wei CJ, Nabel GJ.

Nature. 2012 Sep 27;489(7417):566-70. doi: 10.1038/nature11371. Epub 2012 Aug 29.

PMID:
22932267
42.

Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure.

Wei CJ, Yassine HM, McTamney PM, Gall JG, Whittle JR, Boyington JC, Nabel GJ.

Sci Transl Med. 2012 Aug 15;4(147):147ra114. doi: 10.1126/scitranslmed.3004273.

43.

Interspecies transmission of influenza a viruses between Swine and poultry.

Yassine HM, Lee CW, Saif YM.

Curr Top Microbiol Immunol. 2013;370:227-40. doi: 10.1007/82_2011_180. Review.

PMID:
22167468
44.

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials.

Ledgerwood JE, Wei CJ, Hu Z, Gordon IJ, Enama ME, Hendel CS, McTamney PM, Pearce MB, Yassine HM, Boyington JC, Bailer R, Tumpey TM, Koup RA, Mascola JR, Nabel GJ, Graham BS; VRC 306 Study Team.

Lancet Infect Dis. 2011 Dec;11(12):916-24. doi: 10.1016/S1473-3099(11)70240-7. Epub 2011 Oct 3.

PMID:
21975270
45.

Potential role of viral surface glycoproteins in the replication of H3N2 triple reassortant influenza A viruses in swine and turkeys.

Yassine HM, Khatri M, Lee CW, Saif YM.

Vet Microbiol. 2011 Mar 24;148(2-4):175-82. doi: 10.1016/j.vetmic.2010.09.009. Epub 2010 Sep 16.

PMID:
20965669
47.

Interspecies and intraspecies transmission of influenza A viruses: viral, host and environmental factors.

Yassine HM, Lee CW, Gourapura R, Saif YM.

Anim Health Res Rev. 2010 Jun;11(1):53-72. doi: 10.1017/S1466252310000137. Review.

PMID:
20591213
48.

The high susceptibility of turkeys to influenza viruses of different origins implies their importance as potential intermediate hosts.

Pillai SP, Pantin-Jackwood M, Yassine HM, Saif YM, Lee CW.

Avian Dis. 2010 Mar;54(1 Suppl):522-6. Review.

PMID:
20521688
49.

Characterization of triple reassortant H1N1 influenza A viruses from swine in Ohio.

Yassine HM, Khatri M, Zhang YJ, Lee CW, Byrum BA, O'Quin J, Smith KA, Saif YM.

Vet Microbiol. 2009 Oct 20;139(1-2):132-9. doi: 10.1016/j.vetmic.2009.04.028. Epub 2009 May 4.

PMID:
19477087
50.

Pathobiology of triple reassortant H3N2 influenza viruses in breeder turkeys and its potential implication for vaccine studies in turkeys.

Pillai SP, Pantin-Jackwood M, Jadhao SJ, Suarez DL, Wang L, Yassine HM, Saif YM, Lee CW.

Vaccine. 2009 Feb 5;27(6):819-24. doi: 10.1016/j.vaccine.2008.11.076. Epub 2008 Dec 9.

PMID:
19071183

Supplemental Content

Loading ...
Support Center